| Note: this study is at multiple sites in North Carolina |
| Study title |
Safety, Tolerability, and Efficacy of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis (PRIMIS) |
| Disease or condition |
Primary sclerosing cholangitis |
| Study type |
Interventional (Clinical Trial) |
| Intervention/treatment |
Cilofexor or placebo |
| Phase |
3 |
| Study site 1 |
Carolinas Medical Center, Center for Liver Disease & Transplant (Atrium Health) |
| Study location |
Charlotte, NC |
| Principal investigator name and email |
Andrew deLemos |
| Study coordinator name and email |
Marybeth Schwallie marybeth.schwallie@atriumhealth.org |
| Phone Contact |
704-355-7608 |
| Study site 2 |
Duke University |
| Study location |
Durham |
| Principal investigator |
Andrew Muir, andrew.muir@duke.edu |
| Study coordinator |
Adele Gaskin, adele.gaskin@duke.edu |
| Phone contact |
919-684-0742 |
| Clinicaltrials.gov link |
https://clinicaltrials.gov/ct2/show/NCT03890120 |
